Reaction Details Report a problem with these data
Target
IgG receptor FcRn large subunit p51
Ligand
BDBM50270832
Substrate
n/a
Meas. Tech.
ChEMBL_552584 (CHEMBL956456)
IC50
420±n/a nM
Citation
 Mezo, AR; McDonnell, KA; Castro, A; Fraley, C Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction. Bioorg Med Chem 16:6394-405 (2008) [PubMed]  Article 
Target
Name:
IgG receptor FcRn large subunit p51
Synonyms:
FCGRN_HUMAN | FCGRT | FCRN
Type:
PROTEIN
Mol. Mass.:
39742.86
Organism:
Homo sapiens (Human)
Description:
ChEMBL_627631
Residue:
365
Sequence:
MGVPRPQPWALGLLLFLLPGSLGAESHLSLLYHLTAVSSPAPGTPAFWVSGWLGPQQYLSYNSLRGEAEPCGAWVWENQVSWYWEKETTDLRIKEKLFLEAFKALGGKGPYTLQGLLGCELGPDNTSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSCPHRLREHLERGRGNLEWKEPPSMRLKARPSSPGFSVLTCSAFSFYPPELQLRFLRNGLAAGTGQGDFGPNSDGSFHASSSLTVKSGDEHHYCCIVQHAGLAQPLRVELESPAKSSVLVVGIVIGVLLLTAAAVGGALLWRRMRSGLPAPWISLRGDDTGVLLPTPGEAQDADLKDVNVIPATA
  
Inhibitor
Name:
BDBM50270832
Synonyms:
CHEMBL525265
Type:
Small organic molecule
Emp. Form.:
C86H124N24O22S2
Mol. Mass.:
1910.182
SMILES:
CC(C)C[C@H](N(C)C(=O)CN(C)C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O |r,wU:90.92,105.110,130.136,73.76,29.37,51.61,4.4,43.45,115.119,84.88,wD:62.72,18.26,47.49,109.113,(31.01,-17.09,;31.01,-18.63,;32.35,-19.39,;29.68,-19.39,;29.68,-20.94,;28.35,-21.7,;28.35,-23.24,;27.01,-20.93,;27.01,-19.39,;25.68,-21.71,;24.35,-20.94,;24.36,-19.4,;23.02,-21.71,;23.02,-23.25,;21.69,-20.94,;20.35,-21.71,;19.02,-20.94,;19.02,-19.4,;17.69,-21.72,;17.69,-23.25,;19.02,-24.03,;20.34,-23.26,;21.68,-24.03,;21.68,-25.56,;20.35,-26.34,;19.02,-25.58,;16.35,-20.95,;15.03,-21.73,;15.03,-23.26,;13.69,-20.96,;13.69,-19.41,;15.03,-18.65,;16.44,-19.27,;17.46,-18.12,;16.69,-16.79,;15.18,-17.11,;12.35,-21.71,;11.01,-20.94,;11.01,-19.4,;9.67,-21.72,;8.34,-20.94,;7.01,-21.71,;7.01,-23.25,;5.67,-20.94,;4.34,-21.71,;3,-20.94,;3,-19.39,;1.67,-21.71,;.34,-20.94,;-.99,-21.73,;-.99,-23.26,;-2.32,-20.95,;-2.32,-19.41,;-.99,-18.64,;.35,-19.42,;1.68,-18.64,;1.68,-17.1,;.34,-16.34,;-.99,-17.11,;-3.66,-21.71,;-5,-20.95,;-5,-19.4,;-6.33,-21.72,;-6.33,-23.26,;-5,-24.03,;-5,-25.57,;-3.66,-26.33,;-3.65,-27.87,;-4.99,-28.64,;-2.32,-28.64,;-7.65,-20.94,;-8.97,-21.74,;-8.97,-23.27,;-10.3,-20.96,;-11.65,-21.71,;-10.3,-19.42,;-8.97,-18.66,;-8.97,-17.11,;-10.3,-16.34,;-7.63,-16.35,;1.67,-23.25,;3.22,-23.26,;.13,-23.24,;1.67,-24.79,;5.67,-19.39,;4.34,-18.63,;7,-18.63,;31.01,-21.71,;31.01,-23.25,;32.35,-20.94,;33.68,-21.71,;35.02,-20.94,;35.02,-19.39,;33.69,-18.63,;33.69,-17.1,;35.02,-16.32,;35.01,-14.77,;36.35,-17.08,;36.36,-18.62,;33.68,-23.25,;32.35,-24.02,;35.02,-24.02,;36.59,-23.49,;37.61,-24.82,;36.66,-26.21,;35.26,-25.52,;34.03,-26.45,;32.62,-25.85,;34.01,-27.99,;32.68,-28.76,;31.35,-27.98,;30.01,-28.74,;32.66,-30.3,;33.99,-31.08,;31.31,-31.04,;31.31,-32.58,;32.63,-33.37,;32.61,-34.9,;31.28,-35.65,;33.95,-35.69,;29.96,-33.34,;28.64,-32.56,;29.95,-34.88,;28.61,-35.63,;28.6,-37.17,;29.92,-37.95,;27.25,-37.93,;26.93,-39.58,;25.26,-39.8,;24.55,-38.27,;25.84,-37.41,;25.66,-35.89,;24.23,-35.3,;26.87,-34.95,)|
Structure:
Search PDB for entries with ligand similarity: